- Breaking: National Bank of Canada Reveals Holdings In XRP ETF, Bitcoin ETFs
- Natural gas: European prices surge as LNG flows stall – ING
- Farewell to "K-shaped divergence"? PNC report: The gap in consumption between high- and low-income households in the U.S. will basically disappear by 2026, with the labor market as the key support
- The SEC will discuss a regulatory framework for crypto token issuance.
- From 1.5GW Reservation to $20 Billion Valuation Ambition: Singapore Data Center Operator DayOne Rushes for US IPO
- From 1.5GW Bookings to a $20 Billion Ambition: Singapore Data Center Operator DayOne Races Toward US IPO
- Egypt: MELEIHA Natural Gas Plant Project in the Western Desert to Begin Operations Next Month with a Daily Capacity of 100 Million Cubic Feet
- Bitget Protection Fund valuation climbs to $351M as Bitcoin rallies in July
- Chainlink crypto nears 9.48 resistance as RSI hits overbought 77.61
- Trump Media & Technology Group stock wobbles after $238M quarterly loss
- HIMS & HERS HEALTH, INC. <HIMS.N>: TD COWEN RAISES TARGET PRICE TO $30 FROM $25
- ATS held virtual annual and special shareholders meeting
- MERCK & CO INC <MRK.N>: ARGUS RESEARCH RAISES TARGET PRICE TO $145 FROM $130
- CENTENE CORP <CNC.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- Stellar price risks a deeper correction toward $0.142
- Harvard Apparatus adjusted EBITDA rises 11% year over year to $1.7 million; revenue increases 11% to $22.7 million in 2Q26
- Delfi 1H FY26 PATMI rises 5.4% to US$12.9 million; net sales climb 2.7% to US$266.6 million
- Cadeler buys offshore foundation installer Menck for EUR 501 million
- BOEING <BA.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- NEWMONT <NEM.N>: RAYMOND JAMES RAISES TARGET PRICE TO $131 FROM $128
- RAPID7, INC. <RPD.O>: RAYMOND JAMES RAISES TARGET PRICE TO $15 FROM $8
- SEC Tees Up New Crypto Rulebook As XRP Wobbles
- Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP
- Havila Kystruten targets 10% average cabin revenue growth in 2026
- APPLIED OPTOELECTRONICS, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $178 FROM $151
- BARRICK MINING <B.N>: RAYMOND JAMES CUTS TARGET PRICE TO $56 FROM $58
- Babcock & Wilcox Shares Gain After Signing of Data-Center Power Agreement
- SIONNA THERAPEUTICS, INC. <SION.O>: WEDBUSH CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $5 FROM $53
- Fleury board okays disclosure of Q2 2026 financial results
- Japanese Yen: Wider range with intervention support against US Dollar – HSBC
- Top 3 Price Prediction: Bitcoin (BTC), Ethereum (ETH), XRP (XRP)
- Legacy Gold Mines hits 1.14 g/t gold over 13.5 m from surface at Baner project, Idaho
- GOLD X2 MINING INC : STIFEL INITIATES COVERAGE WITH BUY RATING; PRICE TARGET C$15
- Intensity Therapeutics Q2 FY26 net loss widens 18.53% to $3.01 million
- Freja eID Group to host investor webinar after Q2 report
- 908 Devices forecasts 2026 revenue from continuing operations of $68 million to $70 million
- VERA THERAPEUTICS, INC. <VERA.O>: WEDBUSH CUTS TARGET PRICE TO $34 FROM $43
- OKP 1H FY26 net profit rises 43.8% to S$27.3 million; revenue climbs 9% to S$113.8 million
- SIMON PROPERTY GROUP INC <SPG.N>: STIFEL RAISES TARGET PRICE TO $209 FROM $194
- REVOLUTION MEDICINES, INC. <RVMD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $231 FROM $210
- BlackRock lifts LEG Immobilien voting rights to 10.04% from 10%
- RAPID7, INC. <RPD.O>: STIFEL RAISES TARGET PRICE TO $13 FROM $7
- Deutsche Bank economists anticipate that U.S. gasoline prices will fall by about 2% in July, with both headline and core CPI year-on-year growth rates dropping by approximately 0.1%. The former is expected to decrease from 3.53% to 3.45%, and the latter from 2.59% to 2.51%.
- HINGE HEALTH, INC. <HNGE.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $112 FROM $85
- ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28
- ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47
- Brent crude oil fell by about $1 in the short term, hitting a low of $87.17 per barrel.
- The main contract of Nymex WTI crude oil futures just broke through the $82.00 per barrel mark, last quoted at $81.98 per barrel, down 0.18% on the day.
- REVOLUTION MEDICINES, INC. <RVMD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $231 FROM $210
- Eltek director Amit Foox files initial beneficial ownership statement
- Neo Q2 FY26 adjusted EBITDA more than doubled to USD 57.03 million; revenue rises to USD 205.75 million
- Aasen Sparebank mulls NOK 50 million subordinated bond issue
- US Dollar Index Price Forecast: A break above 100.00 would confirm a double bottom
- Polar Power receives orders for 15 solar hybrid power systems in Solomon Islands
- HINGE HEALTH, INC. <HNGE.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $112 FROM $85
- Superior Group amends, extends $200 million credit facilities with PNC-led lender group to 2031
- Kim Heng expects net loss for HY2026 amid weaker geotechnical survey, vessel trading revenue
- ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47
- Correct: Pet Valu Holdings 2Q EPS C$0.37 >PET.T
- Knowit names Fredrik Ekerhovd CEO effective immediately
- Green Thumb publishes investor presentation on U.S. THC market growth, category leadership strategy
- BEST BUY CO., INC. <BBY.N>: TRUIST SECURITIES RAISES TO BUY FROM HOLD; RAISES TARGET PRICE TO $95 FROM $81
- Correct: Pet Valu Holdings 2Q Rev C$290.7M >PET.T
- Milady memecoin whales sitting on paper profits worth more than $20 million
- ABCELLERA BIOLOGICS INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $30 FROM $12
- Vestis Q3 revenue misses estimates on lower volumes
- Middleby Sees FY26 Adj EPS $6.73-Adj EPS $6.89 >MIDD
- Hub Group delays Q2 10-Q filing as it restates prior financial statements
- Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Middleby Sees 3Q Sales $620M-$640M >MIDD
- Middleby Sees FY26 Sales $2.48B-$2.53B >MIDD
- Middleby Sees 3Q Adj EPS $1.67-Adj EPS $1.83 >MIDD
- C4 Therapeutics 2Q Loss $23.6M >CCCC
- CVRx Says Verrastro Has More Than 30 Years of Medical Device Sales, Marketing Experience >CVRX
- Terrestrial Energy Reported 2Q Cash Burn of $6.4M, a Decrease of $1.5M Compared to 1Q >IMSR
- Neo Performance Materials Raises Full-Year Adjusted EBITDA Guidance to $140M-$150M >NEO.T
- Prelude Therapeutics Q2 FY26 net loss narrows to $13.92 million; revenue turns to $5.7 million
- PATRICK INDUSTRIES, INC. : BENCHMARK CUTS TARGET PRICE TO $115 FROM $135
- Broadwind Q2 FY26 GAAP loss from continuing operations narrows to $0.7 million; revenue rises 67% to $24.3 million
- Endurance Gold reports 9.27 g/t gold over 6.1 m in down-dip Eagle Zone extension at Reliance project
- Excalibur Metals flags new silver-gold soil anomalies at Bellehelen project in Nevada
- Aura Biosciences Q2 FY26 net loss widens to $45.64 million; R&D expense rises to $30.75 million
- Terrestrial Energy Ended 2Q With $283.4M in Cash, Cash Equivalents and Investments >IMSR
- Neo Performance Materials 2Q EPS 38c >NEO.T
- Gain Therapeutics 2Q Research and Development Expenses $2.1M >GANX
- Vestis 3Q Rev $661.7M >VSTS
- Neo Performance Materials 2Q Adj EPS 51c >NEO.T
- Xtant Medical Holdings 2Q Rev $23M >XTNT
- Middleby 2Q Sales $875.5M >MIDD
- C4 Therapeutics 2Q Loss/Shr 18c >CCCC
- Middleby 2Q Adj EPS $2.35 >MIDD
- Middleby 2Q EPS $1.21 >MIDD
- Dow Jones Top Company Headlines at 7 AM ET: Anthropic Tries to Shore Up Investor Confidence Ahead of Blockbuster IPO | Smithfield ...
- Prelude Therapeutics 2Q Rev $5.7M >PRLD
- Kardigan 2Q Loss/Shr $4.61 >KARD
- Xtant Medical Holdings 2Q Loss $9.41M >XTNT
